Literature DB >> 9930071

Association of pure red cell aplasia with T large granular lymphocyte leukaemia.

Y L Kwong1, K F Wong.   

Abstract

AIM: To define the relation between T large granular lymphocyte (T-LGL) leukaemia and pure red cell aplasia in Chinese patients.
METHODS: Patients with T-LGL leukaemia were identified from a consecutive series of Chinese patients with chronic lymphoproliferative disorders. The diagnosis of T-LGL leukaemia was based on typical morphological and immunophenotypical features, and confirmed by the detection of clonal T cell receptor gene rearrangement. The clinicopathological features, response to treatment, and long term follow up were also examined.
RESULTS: Five patients were identified as having T-LGL leukaemia from a consecutive series of 33 Chinese patients with chronic lymphoproliferative disorders. The median follow up time was 45 months. An obvious lymphocytosis was present in only two cases, although an increase in large granular lymphocytes in the peripheral blood was found in four. In one case, the LGL count was within the normal range. Epstein-Barr virus encoded early nuclear RNA was negative in all the cases. There was no evidence of rheumatoid arthritis, and none of the patients presented with recurrent infections. On follow up, pure red cell aplasia occurred at some stage of the disease in all the patients. This responded to treatment with cyclosporin A in two and with antithymocyte globulin in one. Two patients remained transfusion dependent.
CONCLUSIONS: In contrast to Western patients, Chinese patients with T-LGL leukaemia do not appear to suffer from rheumatoid arthritis and recurrent infections, but pure red cell aplasia is a major cause of morbidity in this ethnic group.

Entities:  

Mesh:

Year:  1998        PMID: 9930071      PMCID: PMC500904          DOI: 10.1136/jcp.51.9.672

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  18 in total

1.  Clinical course and prognosis of the lymphoproliferative disease of granular lymphocytes. A multicenter study.

Authors:  F Pandolfi; T P Loughran; G Starkebaum; T Chisesi; T Barbui; W C Chan; J C Brouet; G De Rossi; R W McKenna; F Salsano
Journal:  Cancer       Date:  1990-01-15       Impact factor: 6.860

Review 2.  T gamma-lymphoproliferative disease and related disorders in humans and experimental animals: a review of the clinical, cellular, and functional characteristics.

Authors:  C W Reynolds; K A Foon
Journal:  Blood       Date:  1984-12       Impact factor: 22.113

3.  Large granular lymphocyte leukemia. Report of 38 cases and review of the literature.

Authors:  T P Loughran; G Starkebaum
Journal:  Medicine (Baltimore)       Date:  1987-09       Impact factor: 1.889

4.  Chronic lymphocytic leukaemia of T-cell origin. Immunological and clinical evaluation in eleven patients.

Authors:  J C Brouet; M Sasportes; G Flandrin; J L Preud'Homme; M Seligmann
Journal:  Lancet       Date:  1975-11-08       Impact factor: 79.321

5.  The lymphoproliferative disease of granular lymphocytes. A heterogeneous disorder ranging from indolent to aggressive conditions.

Authors:  G Semenzato; F Pandolfi; T Chisesi; G De Rossi; G Pizzolo; R Zambello; L Trentin; C Agostini; E Dini; M Vespignani
Journal:  Cancer       Date:  1987-12-15       Impact factor: 6.860

6.  A simplified method of detection of clonal rearrangements of the T-cell receptor-gamma chain gene.

Authors:  K P McCarthy; J P Sloane; J H Kabarowski; E Matutes; L M Wiedemann
Journal:  Diagn Mol Pathol       Date:  1992-09

7.  Large granular lymphocyte leukemia. A study of nine cases in a Chinese population.

Authors:  Y L Kwong; K F Wong; L C Chan; R H Liang; J K Chan; C K Lin; T K Chan
Journal:  Am J Clin Pathol       Date:  1995-01       Impact factor: 2.493

8.  Heterogeneity of large granular lymphocyte proliferations: delineation of two major subtypes.

Authors:  W C Chan; S Link; A Mawle; I Check; R K Brynes; E F Winton
Journal:  Blood       Date:  1986-11       Impact factor: 22.113

9.  The role of pentostatin in the treatment of T-cell malignancies: analysis of response rate in 145 patients according to disease subtype.

Authors:  J Mercieca; E Matutes; C Dearden; K MacLennan; D Catovsky
Journal:  J Clin Oncol       Date:  1994-12       Impact factor: 44.544

10.  The spectrum of chronic lymphoproliferative disorders in Chinese people. An analysis of 64 cases.

Authors:  Y L Kwong; K F Wong; L C Chan; R H Liang; J K Chan; D Wei; E K Chiu; C H Chan; D Todd; T K Chan
Journal:  Cancer       Date:  1994-07-01       Impact factor: 6.860

View more
  17 in total

Review 1.  The pathogenesis and treatment of large granular lymphocyte leukemia.

Authors:  Steven Nathaniel Steinway; Francis LeBlanc; Thomas P Loughran
Journal:  Blood Rev       Date:  2014-03-07       Impact factor: 8.250

2.  Large granular lymphocyte cells and immune dysregulation diseases - the chicken or the egg?

Authors:  Anton W Langerak; Jorn L J C Assmann
Journal:  Haematologica       Date:  2018-02       Impact factor: 9.941

3.  MICA polymorphism identified by whole genome array associated with NKG2D-mediated cytotoxicity in T-cell large granular lymphocyte leukemia.

Authors:  Aaron D Viny; Michael J Clemente; Monika Jasek; Medhat Askar; Hemant Ishwaran; Amy Nowacki; Aiwen Zhang; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2010-05-11       Impact factor: 9.941

Review 4.  Immunosuppressive treatment of acquired aplastic anemia and immune-mediated bone marrow failure syndromes.

Authors:  Neal S Young
Journal:  Int J Hematol       Date:  2002-02       Impact factor: 2.490

Review 5.  Large granular lymphocytic leukemia: a brief review.

Authors:  Ekta Rahul; Aparna Ningombam; Shreyam Acharya; Pranay Tanwar; Amar Ranjan; Anita Chopra
Journal:  Am J Blood Res       Date:  2022-02-15

Review 6.  Peripheral T-cell lymphoma.

Authors:  Wing Y Au; Raymond Liang
Journal:  Curr Oncol Rep       Date:  2002-09       Impact factor: 5.075

Review 7.  The root of many evils: indolent large granular lymphocyte leukaemia and associated disorders.

Authors:  Ranran Zhang; Mithun Vinod Shah; Thomas P Loughran
Journal:  Hematol Oncol       Date:  2010-09       Impact factor: 5.271

8.  Therapeutic implications of variable expression of CD52 on clonal cytotoxic T cells in CD8+ large granular lymphocyte leukemia.

Authors:  Sanjay R Mohan; Michael J Clemente; Manuel Afable; Heather N Cazzolli; Nelli Bejanyan; Marcin W Wlodarski; Alan E Lichtin; Jaroslaw P Maciejewski
Journal:  Haematologica       Date:  2009-10       Impact factor: 9.941

9.  T-cell large granular lymphocytic (T-LGL) leukemia: a single institution experience.

Authors:  Aleksandra Sretenovic; Darko Antic; Snezana Jankovic; Mirjana Gotic; Maja Perunicic-Jovanovic; Ljubomir Jakovic; Biljana Mihaljevic
Journal:  Med Oncol       Date:  2009-03-21       Impact factor: 3.064

10.  STAT3 gene mutations and their association with pure red cell aplasia in large granular lymphocyte leukemia.

Authors:  Fumihiro Ishida; Kazuyuki Matsuda; Nodoka Sekiguchi; Hideki Makishima; Chiaki Taira; Kayoko Momose; Sayaka Nishina; Noriko Senoo; Hitoshi Sakai; Toshiro Ito; Yok-Lam Kwong
Journal:  Cancer Sci       Date:  2014-01-22       Impact factor: 6.716

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.